Startup entity
Every one of those 1 sits in a single category, ipo. Hem Securities is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.5 for that window.
Last mentioned: Feb 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, ipo. Hem Securities is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.5 for that window. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline. Gaudium IVF and Women Health appears in 1 tracked Startup story from February 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 32 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Gaudium IVF and Women Health. Shared-story counts are live from our verified record — not editorial picks.
Stock Listing
Shares expected to debut on the NSE and BSE exchanges.
Basis of Allotment
Finalization of share allotment expected for successful bidders.
Final Bidding Day
Last day for investors to subscribe to the ₹125.22 crore issue.
IPO Opens
Public bidding commenced for retail and institutional investors.
Anchor Round
Gaudium IVF finalized anchor investor allocations ahead of the public open.
Gaudium IVF and Women Health's ₹125.22 crore IPO entered its final bidding day with a 3x overall subscription and a steady grey market premium. The offering, consisting entirely of a fresh issue, has seen particularly robust interest from retail investors as the company seeks to expand its fertility clinic network.
Source: The Economic Times
Gaudium IVF and Women Health is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
